U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2011
587
Substance Class Protein
Created
by admin
on Mon Mar 31 18:47:07 GMT 2025
Edited
by admin
on Mon Mar 31 18:47:07 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
E3B2GI648A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NULOJIX
Preferred Name English
BELATACEPT
DASH   EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
BELATACEPT [PURPLE BOOK CDER]
Common Name English
BELATACEPT [MART.]
Common Name English
CTLA-4 (ANTIGEN) (29-TYROSINE,104-GLUTAMIC ACID) (HUMAN EXTRACELLULAR DOMAIN-CONTAINING FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN MONOCLONAL FC DOMAIN-CONTAINING FRAGMENT), BIMOL. (120->120')-DISULFIDE
Common Name English
Belatacept [WHO-DD]
Common Name English
BELATACEPT [USAN]
Common Name English
BELATACEPT [EMA EPAR]
Common Name English
BELATACEPT [VANDF]
Common Name English
BELATACEPT [MI]
Common Name English
BMS-224818
Code English
belatacept [INN]
Common Name English
Classification Tree Code System Code
NDF-RT N0000182830
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
WHO-ATC L04AA28
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
NCI_THESAURUS C574
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
EMA ASSESSMENT REPORTS NULOJIX (AUTHORIZED: GRAFT REJECTION)
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
EMA ASSESSMENT REPORTS NULOJIX (AUTHORIZED: KIDNEY TRANSPLANTATION)
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
FDA ORPHAN DRUG 253907
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
WHO-VATC QL04AA28
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
Code System Code Type Description
NDF-RT
N0000182829
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY T Lymphocyte Costimulation Activity Blockade [PE]
DRUG CENTRAL
5091
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
USAN
QQ-105
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
FDA UNII
E3B2GI648A
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
RXCUI
1112973
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY RxNorm
CAS
706808-37-9
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
NDF-RT
N0000182151
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY CD86-directed Antibody Interactions [MoA]
ChEMBL
CHEMBL1742990
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
SMS_ID
100000092978
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
NCI_THESAURUS
C80255
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
DRUG BANK
DB06681
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
IUPHAR
6892
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
LACTMED
Belatacept
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
WIKIPEDIA
BELATACEPT
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
NDF-RT
N0000182150
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY CD80-directed Antibody Interactions [MoA]
MERCK INDEX
m2293
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY Merck Index
EVMPD
SUB20603
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
INN
8627
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
DAILYMED
E3B2GI648A
Created by admin on Mon Mar 31 18:47:07 GMT 2025 , Edited by admin on Mon Mar 31 18:47:07 GMT 2025
PRIMARY
From To
1_21 1_92
1_48 1_66
1_120 2_120
1_171 1_231
1_277 1_335
2_21 2_92
2_48 2_66
2_171 2_231
2_277 2_335
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_76
N 1_108
N 1_207
N 2_76
N 2_108
N 2_207
O 1_129
O 1_139
O 2_129
O 2_139
Related Record Type Details
BELATACEPT
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Volume of Distribution PHARMACOKINETIC
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966